Fundamental dimension Equity attribute | VYLRLeader $73.56▲+3.43% Cap $49.08BP/E — QuantScore47/100 | 000792.SZPeer —— Cap —P/E — QuantScore— | BIOXPeer $0.2346▼-8.00% Cap $14.83MP/E -0.1x QuantScore36/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical Trend, RSI, MACD & signal consensus | |||
— |
— |
21/100 |
Valuation Multiples, PEG & DCF upside | — | — | 40/100 |
Health Piotroski, Altman Z, leverage & liquidity | — | — | 3/100 |
Growth Revenue / earnings growth & margins | — | — | 26/100 |
Sentiment Analyst ratings, targets & revisions | 47/100 | — | 92/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | — | — | -0.1x |
Forward P/E (next FY) | — | — | 4.7x |
EV / EBITDA (TTM) | — | — | 90.5x |
Price / Sales | — | — | 0.1x |
Price / Free Cash Flow | — | — | 0.3x |
PEG ratio | — | — | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | — | — | 3 / 9 |
Altman Z-Score | — | — | 0.36 (Distress) |
Total debt / equity | — | — | 6.06 |
Quick ratio | — | — | 0.6x |
Interest coverage | — | — | -0.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | — | — | -28.7% |
Net income growth YoY | — | — | -315.6% |
Gross margin (TTM) | — | — | 35.4% |
Operating margin (FY) | — | — | 0.0% |
FCF margin (FY) | — | — | 14.8% |
5. Trailing price performancePrice change over period |
1M return | +9.3% | — | -36.8% |
3M return | +9.3% | — | -31.6% |
6M return | +9.3% | — | -56.7% |
Year to date | +9.3% | — | -82.1% |
1Y return | +9.3% | — | -87.3% |
3Y return | +9.3% | — | -97.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | — — | — — | $-2.10 -993.1% premium |
Wall Street consensus target | $83.60 +13.6% · range $74.00–$90.00 | — — | $8.00 +3310.1% · range $2.00–$15.00 |
Consensus stance | — | — | 80% Buy20% Hold0% Sell |